Pathogenic relevance of Lactobacillus:: a retrospective review of over 200 cases

被引:293
作者
Cannon, JP
Lee, TA
Bolanos, JT
Danziger, LH
机构
[1] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60611 USA
[2] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Serv Pharm, Hines, IL 60141 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med,Ctr Healthcare Studies, Chicago, IL 60611 USA
[4] Univ Illinois, Coll Pharm, Ctr Pharmacoecon Res, Chicago, IL 60612 USA
[5] Univ Illinois, Dept Med, Infect Dis Sect, Chicago, IL 60612 USA
[6] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Midw Ctr Hlth Serv & Policy Res, Hines, IL 60141 USA
关键词
D O I
10.1007/s10096-004-1253-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Given that Lactobacillus has been reported to be the causative pathogen in many types of infection despite debate regarding the organism's clinical significance, a literature review was conducted to investigate the treatments and outcomes of Lactobacillus infections reported to date. In this article, the characteristics of over 200 reported cases of Lactobacillus-associated infections are summarized. Lactobacillus was found to be frequently associated with endocarditis and bacteremia. Lactobacillus was also associated with a variety of other infections including, but not limited to, peritonitis, abscesses, and meningitis. The species casei and rhamnosus were the most common. The isolates tended to be most sensitive to erythromycin and clindamycin and most resistant to vancomycin. The species that was most sensitive to vancomycin was acidophilus. The overall mortality rate was nearly 30%. There was a significant association between mortality and polymicrobial infection (P=0.004). In the subset of patients with bacteremia, increased mortality was associated with inadequate treatment (P=0.001) and polymicrobial bacteremia (P=0.044).
引用
收藏
页码:31 / 40
页数:10
相关论文
共 113 条
[91]   Lactobacillus species as opportunistic pathogens in immunocompromised patients [J].
Schlegel, L ;
Lemerle, S ;
Geslin, P .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1998, 17 (12) :887-888
[92]  
SCHLEIFER CR, 1989, PERITON DIALYSIS INT, V9, P222
[93]   Aortic graft infection by Lactobacillus casei: a case report [J].
Schoon, Y ;
Schuurman, B ;
Buiting, AGM ;
Kranendonk, SE ;
Graafsma, SJ .
NETHERLANDS JOURNAL OF MEDICINE, 1998, 52 (02) :71-74
[94]   PATHOGENIC LACTOBACILLI [J].
SHARPE, ME ;
HILL, LR ;
LAPAGE, SP .
JOURNAL OF MEDICAL MICROBIOLOGY, 1973, 6 (03) :281-286
[95]   LACTOBACILLUS - AN UNUSUAL CASE OF SPLENIC ABSCESS AND SEPSIS IN AN IMMUNOCOMPROMISED HOST [J].
SHERMAN, ME ;
ALBRECHT, M ;
DEGIROLAMI, PC ;
KIRKLEY, SA ;
WOLF, B ;
ELIOPOULOS, GM ;
ROHRER, RJ ;
MONACO, AP .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1987, 88 (05) :659-662
[96]   LACTOBACILLUS PLANTARUM ENDOCARDITIS [J].
SHINAR, E ;
LEITERSDORF, E ;
YEVIN, R .
KLINISCHE WOCHENSCHRIFT, 1984, 62 (24) :1173-1174
[97]   Safety of Lactobacillus strains used as probiotic agents [J].
Sipsas, NV ;
Zonios, DI ;
Kordossis, T .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1283-1284
[98]  
Sloss J M, 1993, J R Army Med Corps, V139, P25
[99]   How safe is safe? A case of Lactobacillus paracasei ssp paracasei endocarditis and discussion of the safety of lactic acid bacteria [J].
Soleman, N ;
Laferl, H ;
Kneifel, W ;
Tucek, G ;
Budschedl, E ;
Weber, H ;
Pichler, H ;
Mayer, HK .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (10) :759-762
[100]   ISOLATION OF VANCOMYCIN-RESISTANT LACTOBACILLI FROM 3 NEUTROPENIC PATIENTS WITH PNEUMONIA [J].
SRISKANDAN, S ;
LACEY, S ;
FISCHER, L .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (08) :649-650